Bone Regeneration with Autologous Plasma, Bone Marrow Stromal Cells, and Porous β-Tricalcium Phosphate in Nonhuman Primates

被引:23
作者
Torigoe, Ichiro [2 ]
Sotome, Shinichi [1 ,2 ]
Tsuchiya, Akio [2 ]
Yoshii, Toshitaka [2 ]
Maehara, Hidetsugu [2 ]
Sugata, Yumi [2 ,3 ]
Ichinose, Shizuko [4 ]
Shinomiya, Kenichi [2 ,3 ,5 ,6 ]
Okawa, Atsushi [2 ]
机构
[1] Tokyo Med & Dent Univ, Grad Sch, Sect Regenerat Therapeut Spine & Spinal Cord, Bunkyo Ku, Tokyo 1138519, Japan
[2] Tokyo Med & Dent Univ, Grad Sch, Sect Orthopaed & Spinal Surg, Tokyo 1138519, Japan
[3] Tokyo Med & Dent Univ, GCOE Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo 1138519, Japan
[4] Tokyo Med & Dent Univ, Instrumental Anal Res Ctr, Tokyo 1138519, Japan
[5] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo 1138519, Japan
[6] Tokyo Med & Dent Univ, Core Core Program Adv Bone & Joint Sci, Tokyo 1138519, Japan
基金
日本学术振兴会;
关键词
MESENCHYMAL STEM-CELLS; TISSUE-ENGINEERED BONE; PLATELET-RICH PLASMA; FIBRIN; SCAFFOLD; TRANSPLANTATION; PROLIFERATION; DEFECTS; SYSTEM; MODEL;
D O I
10.1089/ten.tea.2008.0317
中图分类号
Q813 [细胞工程];
学科分类号
摘要
To potentiate the bone formation capability of bone marrow stromal cell (BMSC)/beta-tricalcium phosphate (beta-TCP) constructs, we devised an autologous plasma-based construct. We tested its effectiveness and investigated the effects of its components on a monkey ectopic bone formation model. The autologous plasma (platelet-rich plasma, PRP, or platelet-poor plasma, PPP)/BMSC/beta-TCP construct (R group or P group) showed significantly more bone formation at 3 and 6 weeks after implantation than a conventional BMSC/beta-TCP construct using a culture medium (M group). There was no significant difference between the P and R groups. Moreover, the P group constructs with a 10-fold lower cell concentration yielded equivalent bone formation to the M group at 5 weeks after implantation. To elucidate the effect of fibrin and serum contained in the plasma, five constructs were prepared using the following cell vehicles: autologous serum+fibrinogen (0, 1, 4, or 16 mg/mL) or phosphate-buffered saline+fibrinogen (4 mg/mL). The serum+fibrinogen (4 mg/mL, physiological concentration of monkeys) construct showed the most abundant bone formation at 3 weeks after implantation, though at 5 weeks no statistical difference existed among the groups. Autologous plasma efficiently promoted osteogenesis of BMSCs/porous beta-TCP constructs, and both fibrin and serum proved to play significant roles in the mechanism.
引用
收藏
页码:1489 / 1499
页数:11
相关论文
共 45 条
[1]   Fibrin glue as an osteoinductive protein in a mouse model [J].
Abiraman, S ;
Varma, HK ;
Umashankar, PR ;
John, A .
BIOMATERIALS, 2002, 23 (14) :3023-3031
[2]   Complications of iliac crest bone graft harvesting [J].
Arrington, ED ;
Smith, WJ ;
Chambers, HG ;
Bucknell, AL ;
Davino, NA .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1996, (329) :300-309
[3]   Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy [J].
Banfi, A ;
Muraglia, A ;
Dozin, B ;
Mastrogiacomo, M ;
Cancedda, R ;
Quarto, R .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (06) :707-715
[4]   ILIAC CREST BONE-GRAFT HARVEST DONOR SITE MORBIDITY - A STATISTICAL EVALUATION [J].
BANWART, JC ;
ASHER, MA ;
HASSANEIN, RS .
SPINE, 1995, 20 (09) :1055-1060
[5]   A biodegradable fibrin scaffold for mesenchymal stem cell transplantation [J].
Bensaïd, W ;
Triffitt, JT ;
Blanchat, C ;
Oudina, K ;
Sedel, L ;
Petite, H .
BIOMATERIALS, 2003, 24 (14) :2497-2502
[6]  
Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
[7]  
2-F
[8]   The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects [J].
Bruder, SP ;
Kraus, KH ;
Goldberg, VM ;
Kadiyala, S .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1998, 80A (07) :985-996
[9]   In vivo osteogenesis assay: a rapid method for quantitative analysis [J].
Dennis, JE ;
Konstantakos, EK ;
Arm, D ;
Caplan, AI .
BIOMATERIALS, 1998, 19 (15) :1323-1328
[10]   Bone marrow stromal cells (BMSCs) in bone engineering: Limitations and recent advances [J].
Derubeis, AR ;
Cancedda, R .
ANNALS OF BIOMEDICAL ENGINEERING, 2004, 32 (01) :160-165